Aflac Incorporated
$ 109.24
0.18%
04 Dec - close price
- Market Cap 58,424,992,000 USD
- Current Price $ 109.24
- High / Low $ 110.14 / 109.00
- Stock P/E 14.35
- Book Value 54.57
- EPS 7.61
- Next Earning Report 2026-02-03
- Dividend Per Share $2.24
- Dividend Yield 2.05 %
- Next Dividend Date 2026-03-02
- ROA 0.03 %
- ROE 0.16 %
- 52 Week High 115.24
- 52 Week Low 95.64
About
Aflac Incorporated (ticker: AFL) is a premier provider of supplemental insurance in the United States, recognized for its comprehensive range of products aimed at alleviating the financial impact of unanticipated medical expenses. Boasting a significant market position in both the U.S. and Japan, Aflac excels in areas such as cancer and accident insurance, leveraging its strong brand reputation and customer loyalty. The company showcases robust financial health, evident in its ongoing revenue growth and sound balance sheet, reinforcing its ability to drive shareholder value while adapting to the dynamic healthcare environment.
Analyst Target Price
$111.08
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-04 | 2025-08-05 | 2025-04-30 | 2025-02-05 | 2024-10-30 | 2024-07-31 | 2024-05-01 | 2024-01-31 | 2023-11-01 | 2023-08-01 | 2023-04-26 | 2023-02-01 |
| Reported EPS | 2.49 | 1.73 | 1.66 | 1.56 | 2.16 | 1.83 | 1.66 | 1.25 | 1.84 | 1.62 | 1.55 | 1.4 |
| Estimated EPS | 1.74 | 1.71 | 1.67 | 1.62 | 1.68 | 1.6 | 1.58 | 1.45 | 1.49 | 1.44 | 1.4 | 1.21 |
| Surprise | 0.75 | 0.02 | -0.01 | -0.06 | 0.48 | 0.23 | 0.08 | -0.2 | 0.35 | 0.18 | 0.15 | 0.19 |
| Surprise Percentage | 43.1034% | 1.1696% | -0.5988% | -3.7037% | 28.5714% | 14.375% | 5.0633% | -13.7931% | 23.4899% | 12.5% | 10.7143% | 15.7025% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-03 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 1.7 |
| Currency | USD |
Previous Dividend Records
| Mar 2026 | Dec 2025 | Jan 1970 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-03-02 | 2025-12-01 | None | 2025-06-02 | 2025-03-03 | 2024-12-02 | 2024-09-02 | 2024-06-03 | 2024-03-01 | 2023-12-01 |
| Amount | $0.61 | $0.58 | $0.58 | $0.58 | $0.58 | $0.5 | $0.5 | $0.5 | $0.5 | $0.42 |
Next Dividend Records
| Dividend per share (year): | $2.24 |
| Dividend Yield | 2.05% |
| Next Dividend Date | 2026-03-02 |
| Ex-Dividend Date | 2026-02-18 |
Recent News: AFL
2025-12-03 14:39:00
The Zacks Accident and Health Insurance industry is expected to grow due to increased underwriting exposure and demand for supplemental health products, despite challenges like pricing pressure and rising medical costs. Key players like Aflac, Unum Group, Globe Life, and Trupanion are highlighted for their strategic advancements, strong financial performances, and adoption of technology. The industry overall shows weak near-term prospects due to a negative earnings outlook but is leveraging technology and improved claims frequency for long-term growth.
2025-12-02 19:06:08
This article identifies four accident and health insurers—Aflac (AFL), Unum Group (UNM), Globe Life (GL), and Trupanion (TRUP)—that are poised for growth despite challenges like rising medical costs and pricing pressure. The industry benefits from increased underwriting exposure, demand for supplemental health products, and technological advancements like AI. However, the sector faces headwinds from inflation and its overall Zacks Industry Rank suggests weak near-term prospects.
2025-12-02 12:21:31
Aflac (AFL) is underperforming the Nasdaq, with its stock up only 2.5% in the last three months compared to the Nasdaq Composite's 8.5% rise. Despite long-term underperformance relative to the Nasdaq, Aflac has outperformed peer MetLife (MET) and maintains a consensus "Hold" rating with analysts. The company recently declared a dividend increase, marking its 43rd consecutive year of dividend growth.
2025-12-02 09:00:00
Ameriflex and Aflac have announced a partnership where Ameriflex will administer consumer-directed health (CDH) services for Aflac in the public sector market. This collaboration aims to provide seamless delivery of spending accounts like FSAs and HSAs, enhancing Aflac's offerings and customer experience for public sector clients. Both companies emphasize their shared commitment to excellent service and innovative solutions to deliver value and financial protection.
2025-12-02 08:00:00
Ameriflex and Aflac have partnered to streamline consumer-directed health care (CDH) administration in the public sector market. Ameriflex will serve as Aflac's administrative partner for CDH services, initially focusing on spending accounts like FSAs and HSAs. This collaboration aims to provide enhanced customer experience and deliver comprehensive benefit administration solutions to Aflac's public sector clients.
2025-12-02 07:33:00
MetLife Inc. (MET) has shown underperformance compared to the Financial Select Sector SPDR Fund (XLF) over various timeframes, despite its large market capitalization and strong Q3 2025 results. The stock has dipped 13.9% from its 52-week high and is down 6.8% YTD, while its rival Aflac has outperformed. Analysts, however, remain moderately optimistic with a consensus rating of "Moderate Buy" and a significant premium on the mean price target.
